Aaron Kantoff - 19 Oct 2023 Form 3 Insider Report for Tourmaline Bio, Inc. (TRML)

Role
Director
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
Issuer symbol
TRML
Transactions as of
19 Oct 2023
Net transactions value
$0
Form type
3
Filing time
23 Oct 2023, 18:31:03 UTC
Previous filing
18 Nov 2021
Next filing
26 Oct 2023

No securities are beneficially owned.

Remarks:

No Table I or Table II securities beneficially owned Exhibit List - Exhibit 24 - Power of Attorney